1
|
Huang J, Shia K. Development of a Cross‐Conjugated Vinylogous [4+2] Anionic Annulation and Application to the Total Synthesis of Natural Antibiotic (±)‐ABX. Angew Chem Int Ed Engl 2020. [DOI: 10.1002/ange.201914657] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Affiliation(s)
- Jing‐Kai Huang
- Institute of Biotechnology and Pharmaceutical ResearchNational Health Research Institutes 35 Keyan Road Zhunan Miaoli County 35053 Taiwan, R.O.C
| | - Kak‐Shan Shia
- Institute of Biotechnology and Pharmaceutical ResearchNational Health Research Institutes 35 Keyan Road Zhunan Miaoli County 35053 Taiwan, R.O.C
| |
Collapse
|
2
|
Huang JK, Shia KS. Development of a Cross-Conjugated Vinylogous [4+2] Anionic Annulation and Application to the Total Synthesis of Natural Antibiotic (±)-ABX. Angew Chem Int Ed Engl 2020; 59:6540-6545. [PMID: 31944523 PMCID: PMC7187479 DOI: 10.1002/anie.201914657] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/16/2019] [Revised: 01/02/2020] [Indexed: 12/14/2022]
Abstract
The cross‐conjugated vinylogous [4+2] anionic annulation has been newly developed, the cascade process of which has a high preference for regiochemical control and chemoselectivity, giving rise to exclusively Michael‐type adducts in moderate to high yields (up to 94 %, 35 examples). By making use of this approach as a key operation, the first total synthesis of natural antibiotic ABX, in racemic form, has been successfully achieved in a concise 7‐step sequence with an overall yield of about 20 %.
Collapse
Affiliation(s)
- Jing-Kai Huang
- Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, 35 Keyan Road, Zhunan, Miaoli County, 35053, Taiwan, R.O.C
| | - Kak-Shan Shia
- Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, 35 Keyan Road, Zhunan, Miaoli County, 35053, Taiwan, R.O.C
| |
Collapse
|
3
|
Abstract
We report the total synthesis of (±)-antroquinonol based on a concise and efficient route.
Collapse
Affiliation(s)
- Xiaoming Wang
- Beijing National Laboratory for Molecular Sciences
- Key Laboratory of Bioorganic Chemistry and Molecular Engineering of Ministry of Education
- Department of Chemical Biology
- College of Chemistry and Molecular Engineering
- Synthetic and Functional Biomolecules Center
| | - Chao Du
- Beijing National Laboratory for Molecular Sciences
- Key Laboratory of Bioorganic Chemistry and Molecular Engineering of Ministry of Education
- Department of Chemical Biology
- College of Chemistry and Molecular Engineering
- Synthetic and Functional Biomolecules Center
| | - Benke Hong
- Beijing National Laboratory for Molecular Sciences
- Key Laboratory of Bioorganic Chemistry and Molecular Engineering of Ministry of Education
- Department of Chemical Biology
- College of Chemistry and Molecular Engineering
- Synthetic and Functional Biomolecules Center
| | - Xiaoguang Lei
- Beijing National Laboratory for Molecular Sciences
- Key Laboratory of Bioorganic Chemistry and Molecular Engineering of Ministry of Education
- Department of Chemical Biology
- College of Chemistry and Molecular Engineering
- Synthetic and Functional Biomolecules Center
| |
Collapse
|
4
|
Zhang BB, Hu PF, Huang J, Hu YD, Chen L, Xu GR. Current Advances on the Structure, Bioactivity, Synthesis, and Metabolic Regulation of Novel Ubiquinone Derivatives in the Edible and Medicinal Mushroom Antrodia cinnamomea. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY 2017; 65:10395-10405. [PMID: 29125753 DOI: 10.1021/acs.jafc.7b04206] [Citation(s) in RCA: 28] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Abstract
In recent years, Antrodia cinnamomea has attracted great attention around the world as an extremely precious edible and medicinal mushroom. Ubiquinone derivatives, which are characteristic metabolites of A. cinnamomea, have shown great bioactivities. Some of them have been regarded as promising therapeutic agents and approved into clinical trial by the U.S. Food and Drug Administration. Although some excellent reviews have been published covering different aspects of A. cinnamomea, this review brings, for the first time, complete information about the structure, bioactivity, chemical synthesis, biosynthesis, and metabolic regulation of ubiquinone derivatives in A. cinnamomea. It not only advances our knowledge on the bioactive metabolites, especially the ubiquinone derivatives, in A. cinnamomea but also provides valuable information for the investigation on other edible and medicinal mushrooms.
Collapse
Affiliation(s)
- Bo-Bo Zhang
- Key Laboratory of Carbohydrate Chemistry and Biotechnology, School of Biotechnology, Jiangnan University , Wuxi, Jiangsu 214122, People's Republic of China
| | - Peng-Fei Hu
- Key Laboratory of Carbohydrate Chemistry and Biotechnology, School of Biotechnology, Jiangnan University , Wuxi, Jiangsu 214122, People's Republic of China
| | - Jing Huang
- Key Laboratory of Carbohydrate Chemistry and Biotechnology, School of Biotechnology, Jiangnan University , Wuxi, Jiangsu 214122, People's Republic of China
| | - Yong-Dan Hu
- Yunnan Institute of Food Safety, Kunming University of Science and Technology , Kunming, Yunnan 650500, People's Republic of China
| | - Lei Chen
- Key Laboratory of Carbohydrate Chemistry and Biotechnology, School of Biotechnology, Jiangnan University , Wuxi, Jiangsu 214122, People's Republic of China
| | - Gan-Rong Xu
- Key Laboratory of Carbohydrate Chemistry and Biotechnology, School of Biotechnology, Jiangnan University , Wuxi, Jiangsu 214122, People's Republic of China
| |
Collapse
|
5
|
Hsu CS, Fang JM. Synthesis of (+)-Antroquinonol and Analogues by Using Enantioselective Michael Reactions of Benzoquinone Monoketals. European J Org Chem 2016. [DOI: 10.1002/ejoc.201600542] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Affiliation(s)
- Che-Sheng Hsu
- Department of Chemistry; National Taiwan University; 106 Taipei Taiwan
| | - Jim-Min Fang
- Department of Chemistry; National Taiwan University; 106 Taipei Taiwan
| |
Collapse
|
6
|
Villaume MT, Sella E, Saul G, Borzilleri R, Fargnoli J, Johnston KA, Zhang H, Fereshteh MP, Dhar TGM, Baran PS. Antroquinonol A: Scalable Synthesis and Preclinical Biology of a Phase 2 Drug Candidate. ACS CENTRAL SCIENCE 2016; 2:27-31. [PMID: 27163023 PMCID: PMC4827469 DOI: 10.1021/acscentsci.5b00345] [Citation(s) in RCA: 24] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 10/23/2015] [Indexed: 06/05/2023]
Abstract
The fungal-derived Taiwanese natural product antroquinonol A has attracted both academic and commercial interest due to its reported exciting biological properties. This reduced quinone is currently in phase II trials (USA and Taiwan) for the treatment of non-small-cell lung carcinoma (NSCLC) and was recently granted orphan drug status by the FDA for the treatment of pancreatic cancer and acute myeloid leukemia. Pending successful completion of human clinical trials, antroquinonol is expected to be commercialized under the trade name Hocena. A synthesis-enabled biological re-examination of this promising natural product, however, reveals minimal in vitro and in vivo antitumor activity in preclinical models.
Collapse
Affiliation(s)
- Matthew T. Villaume
- Department
of Chemistry, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, United States
| | - Eran Sella
- Department
of Chemistry, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, United States
| | - Garrett Saul
- Department
of Chemistry, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, United States
| | - Robert
M. Borzilleri
- Departments
of Discovery Chemistry, Oncology Discovery and Leads Discovery &
Optimization, Preclinical Optimization, Bristol-Myers Squibb Co., Route 206 and Province Line Road, Princeton, New Jersey 08543, United States
| | - Joseph Fargnoli
- Departments
of Discovery Chemistry, Oncology Discovery and Leads Discovery &
Optimization, Preclinical Optimization, Bristol-Myers Squibb Co., Route 206 and Province Line Road, Princeton, New Jersey 08543, United States
| | - Kathy A. Johnston
- Departments
of Discovery Chemistry, Oncology Discovery and Leads Discovery &
Optimization, Preclinical Optimization, Bristol-Myers Squibb Co., Route 206 and Province Line Road, Princeton, New Jersey 08543, United States
| | - Haiying Zhang
- Departments
of Discovery Chemistry, Oncology Discovery and Leads Discovery &
Optimization, Preclinical Optimization, Bristol-Myers Squibb Co., Route 206 and Province Line Road, Princeton, New Jersey 08543, United States
| | - Mark P. Fereshteh
- Departments
of Discovery Chemistry, Oncology Discovery and Leads Discovery &
Optimization, Preclinical Optimization, Bristol-Myers Squibb Co., Route 206 and Province Line Road, Princeton, New Jersey 08543, United States
| | - T. G. Murali Dhar
- Departments
of Discovery Chemistry, Oncology Discovery and Leads Discovery &
Optimization, Preclinical Optimization, Bristol-Myers Squibb Co., Route 206 and Province Line Road, Princeton, New Jersey 08543, United States
| | - Phil S. Baran
- Department
of Chemistry, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, United States
| |
Collapse
|